Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
Karl Swedberg(Brigham and Women's Hospital), Willem J. Remme(AstraZeneca (United Kingdom))
Cited by 2,261
Related Papers
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|Survey of Anesthesiology|2000|2.9k
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
|New England Journal of Medicine|2003|2.5k
Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies
|European Heart Journal|2012|1.3k